Blog Communication Omnicell Pharmaceutical Companies 
Omnicell
JANUARY 10, 2023
There was bipartisan support for the program at the hearing and support for measures such as requiring pharmaceutical companies to publish their prices in a password protected site on HRSA's website. Four of the five staffers originally involved in the investigation now work for or lobby for the pharmaceutical industry.
Omnicell
SEPTEMBER 5, 2022
Pharma’s Challenges to 340B During July and August, several large pharmaceutical companies challenged the operation of the 340B program. For more information on the programs history and a digestable synopsis of the 340B program explained , visit our blog! John Thune (R-S.D.), Debbie Stabenow (D-Mich.),
Expert insights. Personalized for you.
96 
Let's personalize your content